What is the maximum recommended daily dose of valsartan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Valsartan

The maximum recommended daily dose of valsartan is 320 mg total per day, administered as 160 mg twice daily for heart failure, or 320 mg once daily for hypertension. 1, 2, 3

Dosing by Indication

Hypertension

  • Maximum dose: 320 mg once daily 2, 3
  • Starting dose: 80-160 mg once daily
  • The antihypertensive effect is substantially present within 2 weeks, with maximal reduction generally attained after 4 weeks
  • Doses beyond 80 mg provide incremental benefit, though adding a diuretic has greater effect than dose increases beyond 80 mg 3

Heart Failure with Reduced Ejection Fraction (HFrEF)

  • Maximum dose: 160 mg twice daily (320 mg total daily) 1, 4, 5, 3
  • Starting dose: 40 mg twice daily
  • Uptitrate to 80 mg twice daily, then 160 mg twice daily as tolerated
  • This is the target dose proven in clinical trials to reduce cardiovascular mortality and heart failure hospitalizations 1, 4, 5
  • Mean dose achieved in clinical trials was 254 mg total daily 4, 5

Post-Myocardial Infarction

  • Maximum dose: 160 mg twice daily (320 mg total daily) 6, 3
  • Starting dose: 20 mg twice daily (can be initiated as early as 12 hours post-MI)
  • Uptitrate within 7 days to 40 mg twice daily, then to target maintenance dose of 160 mg twice daily as tolerated

Critical Dosing Principles

Guideline-directed medical therapy requires titration to target doses shown to be efficacious in randomized controlled trials, not just symptom improvement. 1, 4, 5 The evidence demonstrates a dose-response relationship with improved outcomes, meaning that treating at less than target doses may result in worse clinical outcomes in patients who could tolerate higher doses 1.

Titration Strategy

  • Adjust doses as frequently as every 1-2 weeks depending on symptoms, vital signs, and laboratory findings 4, 5
  • Continue uptitration even if symptoms improve at lower doses, unless not tolerated
  • The goal is the maximally tolerated dose, ideally reaching the target dose of 320 mg total daily 1

Important Caveats

Pediatric Dosing (Ages 1-16 years)

  • Maximum dose: 4 mg/kg once daily (not to exceed 160 mg total daily) 3
  • Not recommended in children under 1 year of age

Dose Adjustments

  • Consider dose reduction if symptomatic hypotension or renal dysfunction occurs 3
  • In patients with volume depletion, consider lower starting doses
  • At least 50% of target dose should be achieved when possible, as this threshold is used in quality performance measures 1

Formulation Considerations

Critical: Valsartan tablets and oral suspension are NOT interchangeable on a milligram-per-milligram basis. The suspension provides 60% higher systemic exposure (AUC) compared to tablets 3. When switching between formulations, dose adjustment is necessary.

The evidence strongly supports pushing to the maximum tolerated dose of 320 mg total daily rather than settling for lower doses that may provide suboptimal clinical benefit, particularly in heart failure patients where mortality and morbidity reduction are dose-dependent 1, 4, 5, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.